|
|
.
See Category: Neoplasms
See Header: Basal cell carcinoma of skin of trunk
ICD-10 (CM) Code and Descriptor
|
C44.519 |
Basal cell carcinoma of skin of other part of trunk
|
C44519 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.63%
|
20.18%
|
7.68%
|
4.02%
|
2.70%
|
2.02%
|
1.85%
|
1.43%
|
1.16%
|
0.82%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.519*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
12,874
|
17,156
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4,581
|
4,596
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
2,322
|
2,322
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
2,266
|
2,266
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
1,881
|
1,929
|
|
17262
|
DSTRJ MAL LES T/A/L 1.1-2.0 |
1,852
|
2,010
|
|
17000
|
DESTRUCT PREMALG LESION |
1,469
|
1,469
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
1,169
|
1,184
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
1,074
|
3,231
|
|
11103
|
TANGNTL BX SKIN EA SEP/ADDL |
980
|
1,354
|
|
17261
|
DSTRJ MAL LES T/A/L .6-1.0CM |
873
|
952
|
|
17313
|
MOHS 1 STAGE T/A/L |
864
|
902
|
|
13101
|
CMPLX RPR TRUNK 2.6-7.5 CM |
789
|
789
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
687
|
695
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
617
|
17,758
|
|
J3010
|
FENTANYL CITRATE INJECTION |
541
|
856
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
526
|
533
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
502
|
1,816
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
469
|
469
|
|
12034
|
INTMD RPR S/TR/EXT 7.6-12.5 |
448
|
447
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.519 related to the following DRG Codes:
606-607
|
